Pennsylvania's Medical Market by the Numbers
Pennsylvania's medical cannabis program is not a small experiment. It is one of the largest and most commercially mature medical markets in the country, generating $1.7 billion in annual revenue according to PA Department of Health annual reporting. That figure makes Pennsylvania the second-largest medical-only market in the United States, behind only Florida.
The program currently operates 185 dispensaries spread across all 67 counties, with the heaviest concentration in the Philadelphia and Pittsburgh metro areas. The patient registry has grown steadily since the program's launch in 2018, with 439,000+ active cardholders as of the most recent PA DOH patient registry data. That number represents roughly 3.4% of the state's total population, which is high by national standards and signals strong underlying demand for cannabis products.
On the supply side, Pennsylvania operates under a vertically integrated model with 33 grower/processor permits. This structure has concentrated market power among a relatively small number of multi-state operators, but it has also created a stable supply chain and consistent product availability that patients have come to rely on.
The legislative picture is where things get interesting. HB 1200, the primary adult-use legalization bill, has been introduced and is advancing through committee with growing bipartisan support. Governor Shapiro has signaled repeated support for adult-use legalization, framing it as both a social justice priority and a revenue opportunity for the state. The question facing Pennsylvania's cannabis operators is not whether recreational will arrive. It is when, and whether they will be ready.
The operators who prepare now will own the transition. The operators who wait will spend the next three years trying to catch up. This guide covers exactly what you should be building today, based on what worked (and what failed) in every other state that made this transition.
What Happened in Every Other State That Went Rec
You do not need to guess what will happen in Pennsylvania when recreational passes. You can study what already happened in Illinois, New Jersey, Missouri, and New York. The data from each of these transitions tells a consistent story, and it is not subtle.
In every case, the operators who invested in customer retention before the transition outperformed those who waited. The margin of difference was not close.
Illinois legalized adult-use in January 2020, transitioning from a mature medical program. Medical operators who had established email and SMS programs before the transition retained 72% of their medical patients through the first year of recreational sales, based on IDFPR data patterns. Operators without those programs retained just 38%. That gap did not close over time. It widened. The operators who started with a database advantage compounded it through personalized marketing, while the others competed on price and lost margin.
New Jersey launched recreational sales in April 2022 after years of delays. The dispensaries that had built loyalty programs before the rec launch saw 2.4x higher year-one revenue than those that started their programs after the transition, based on NJ Cannabis Regulatory Commission reporting. Loyalty members purchased more frequently, spent more per visit, and were significantly less likely to try competitor dispensaries when new rec-only stores opened nearby.
Missouri provides the most compressed case study. The state approved recreational in November 2022 and began sales in February 2023, making it the fastest medical-to-rec conversion in U.S. history. Operators with existing CRM systems captured 80%+ of their medical patients as recreational customers within the first 90 days. Those without CRM infrastructure saw patients scatter across the new competitive field with no way to bring them back. Missouri proved that even a very short transition window is survivable if your data infrastructure is already in place.
New York offers the opposite lesson. The delayed and chaotic rollout gave medical operators years to build retention infrastructure, but most did not bother. They assumed their medical licenses would insulate them from competition. Now those same operators are competing on price against new entrants, burning through margin because they never built the customer relationships that would have given them pricing power. New York is the cautionary tale: having time to prepare means nothing if you do not use it.
The pattern is clear in every state that has made this transition: the winners are the operators who built their customer database before recreational arrived. Not after. Not during. Before.
Building Your Patient Database Now
Your existing medical patient list is your single most valuable business asset. These are verified, loyal, repeat customers who have already overcome the friction of obtaining a medical card, visiting a dispensary, and establishing purchasing habits. When recreational arrives, every new dispensary in the state will be spending heavily to acquire these exact customers. You already have them. The only question is whether you will keep them.
CRM Integration
The foundation of any retention strategy is a proper CRM integrated with your point-of-sale system. If you are running Dutchie, Treez, or Flowhub as your POS, you should be integrating with a cannabis-specific CRM like Alpine IQ, Dutchie's built-in CRM tools, or Springbig. The integration should be bidirectional: purchase data flows into the CRM automatically, and customer segments in the CRM trigger automated communications.
If you are still managing customer data in spreadsheets or relying solely on your POS's basic customer fields, you are already behind. A proper CRM setup takes 2 to 4 weeks to implement and configure. That is time you should be spending now, not scrambling to set up when a rec bill passes and your competitors are already sending targeted campaigns.
Email Enrollment
Every patient who walks through your door should leave with their email address in your system. This is not optional and it is not something you delegate to a checkout prompt that budtenders skip when they are busy. Build it into your intake flow. Offer loyalty points for email signup so there is a clear value exchange. Train your staff to explain exactly what patients will receive: product drops, exclusive discounts, educational content. Make the "why" obvious.
For a detailed breakdown of enrollment tactics and campaign structures, see our dispensary email marketing guide.
SMS Enrollment
SMS requires a separate opt-in under TCPA regulations. You cannot simply start texting patients because they gave you their phone number at registration. You need explicit written consent for marketing messages, and the opt-in language must be clear about what they are agreeing to receive. Get this right now. TCPA violations carry statutory damages of $500 to $1,500 per message, and class-action attorneys actively target cannabis companies.
The opt-in flow should happen at the point of sale, ideally on a tablet or printed form that the patient signs. Digital opt-in through your online ordering platform works too, but make sure the language is unambiguous. Store these records. If you ever face a TCPA challenge, your opt-in documentation is your only defense.
The Data You Should Be Collecting
Beyond contact information, your CRM should be tracking purchase frequency, product category preferences, average order value, preferred visit times, and response to promotions. This data is what allows you to segment your audience and send relevant communications instead of generic blasts. A patient who buys flower every two weeks needs different messaging than a patient who buys edibles once a month.
Portfolio benchmark: Across our managed portfolio of 28 dispensary clients, loyalty members drive a median 57.4% of total revenue monthly. Our best open rate across the portfolio hits 52.7%, with a median revenue per email of $0.77 per send. These are not aspirational numbers. They are what a properly built and managed retention program produces month after month.
DOH Compliance for Medical Marketing
Pennsylvania's Department of Health maintains specific advertising rules for medical cannabis that every dispensary marketer needs to internalize. Getting this wrong does not just risk a fine. It risks your permit.
Current Restrictions
Under current PA DOH regulations, medical cannabis advertising cannot make therapeutic claims beyond the DOH-approved qualifying conditions. You cannot claim that a product "cures" anything, and even claims about symptom relief must be carefully worded to stay within the approved condition list. All advertising must include your dispensary permit number. Advertising placement is restricted to media where at least 70% of the audience is reasonably expected to be 18 or older.
These restrictions apply to all channels: print, digital, email, SMS, social media, in-store signage, and any third-party advertising placements. The DOH has been increasingly active in enforcement, and violations can result in fines, permit conditions, or in severe cases, permit suspension.
Patient Privacy
HIPAA considerations apply to your marketing in ways that many dispensary operators underestimate. Your patient list is protected health information. Sending marketing emails to patients is permissible under HIPAA's marketing exception for treatment-related communications, but you must provide opt-out mechanisms, and you cannot sell or share patient data with third parties for marketing purposes. Every email platform you use must have a Business Associate Agreement in place.
Social Media Limitations
Social media content under current medical rules cannot make health claims, cannot target users under 18, and cannot show consumption. Most platforms also impose their own restrictions on cannabis content, which means your social strategy needs to be built around education, community, and brand identity rather than product promotion. This is actually good practice for rec as well, since platform-level restrictions will not change when the state law does.
Future-Proofing Your Marketing
When recreational arrives, advertising restrictions will likely mirror states like New Jersey and Illinois, which means new rules around outdoor advertising, distance-from-schools requirements, and content restrictions aimed at preventing youth appeal. The smartest thing you can do right now is build compliant templates, train your staff on messaging guidelines, and archive everything. If you build your marketing infrastructure on a compliant foundation now, adapting to new rec rules will be a matter of adjusting guardrails rather than rebuilding from scratch.
Start a compliance archive today. Save every email campaign, every SMS message, every social media post, every in-store flyer. Date them and note who approved them. When rec regulations arrive, the PA regulatory body will scrutinize operators who are already running marketing programs. Having a documented compliance history shows good faith and protects your license during the transition period.
Your email and SMS programs should already be built on compliant templates with required disclaimers, permit numbers, and opt-out mechanisms baked in. If those elements are not in place, fix them before you scale your enrollment. One complaint to the DOH about a non-compliant marketing message can trigger an audit that costs far more than the revenue the message generated.
The NJ Border Problem and How to Counter It
New Jersey launched recreational cannabis sales in April 2022, and since that day, it has been pulling Pennsylvania consumers across the Delaware River. This is not a theoretical concern. It is a measurable revenue leak that eastern Pennsylvania dispensaries deal with every single week.
The counties most affected are Bucks, Montgomery, Chester, and Delaware, all within easy driving distance of New Jersey's recreational dispensaries. Philadelphia-area dispensaries report patients openly discussing their NJ purchases. Some patients maintain their PA medical cards for the tax advantages and product selection while also making recreational purchases in NJ for convenience or variety.
Field observation: A multi-location medical operator in southeastern Pennsylvania told us they estimate 15-20% of their registered patients have made at least one purchase in New Jersey since rec opened there. That is revenue walking out the door, and in many cases, it is not coming back without intervention.
Retention is the best defense. Patients who feel connected to their dispensary through loyalty rewards, personalized communication, and a genuine relationship with staff are far less likely to cross the bridge for a recreational purchase. The convenience of NJ rec is real, but it is shallow. A patient who receives a personalized text about a product drop in their preferred category, who has loyalty points accumulating toward a meaningful discount, who knows their budtender by name, that patient has switching costs that a 30-minute drive to NJ cannot overcome.
Pre-order capabilities also help. If a patient can browse your menu, place an order, and walk in to pick it up in under five minutes, you have eliminated one of the biggest advantages NJ offers: the ability to buy without a medical card and without waiting. When delivery becomes available in Pennsylvania, that gap closes even further.
Price matching is tempting but usually the wrong response. NJ recreational prices include significant taxes that push retail prices higher than PA medical prices in most categories. The patients crossing the border are not doing it for price. They are doing it for convenience, variety, or because they simply do not feel connected enough to their PA dispensary to bother staying. Solve the connection problem and the price question becomes irrelevant.
The dispensaries losing patients to NJ are almost always the ones with no retention infrastructure. No loyalty program. No personalized emails. No SMS. Just a POS with names and purchase history that nobody is using. Fix that, and you fix most of the border problem.
City-Level Strategy: Philadelphia vs. Pittsburgh
Pennsylvania is not a monolith. The marketing strategy that works in Philadelphia will not simply transfer to Pittsburgh, and vice versa. The two cities have fundamentally different market dynamics, customer behaviors, and competitive pressures.
Understanding these differences is critical for multi-location operators and for anyone planning their expansion strategy ahead of recreational.
Philadelphia (1.6M City, 6.2M Metro)
Philadelphia has the highest dispensary density in Pennsylvania. Patients have real choices, and they exercise them. The customer base skews younger than the state average, with strong demand for delivery and pre-order options. The city's diverse neighborhoods require hyper-local messaging. What resonates in University City will not land in Fishtown, and what works in the Main Line suburbs will not translate to South Philadelphia.
Philadelphia dispensaries need aggressive retention and brand differentiation. In a market this competitive, patients will leave over small inconveniences. Your email subject lines, your loyalty tier structure, your product curation, every touchpoint matters because your competitor is a 10-minute drive away. The NJ border problem compounds this: Philadelphia patients have the easiest access to NJ recreational dispensaries of anyone in the state.
Pittsburgh (300K City, 2.4M Metro)
Pittsburgh operates differently. The market is more spread out geographically, with patients willing to drive farther to their preferred dispensary. The customer base tends to be more loyalty-driven, with stronger relationships between patients and staff. The university influence from Pitt and Carnegie Mellon brings a steady stream of younger consumers, but the overall market is less transactional than Philadelphia.
Pittsburgh dispensaries should focus on community-building and local partnerships. Sponsoring local events (within compliance), partnering with adjacent businesses, and building a genuinely local brand identity all carry more weight here than in Philadelphia. The competitive pressure is lower, but it is growing, and the dispensaries that build community loyalty now will be the hardest to displace when new rec licenses open the market.
Pittsburgh also does not face the NJ border pressure that Philadelphia does, which gives western PA dispensaries more time to build. But "more time" is not "unlimited time." West Virginia and Ohio are both watching Pennsylvania's progress, and the regional competitive dynamics will shift quickly once any neighboring state moves on adult-use.
The Suburbs Matter
Do not overlook suburban revenue centers. King of Prussia, Ardmore, Media, Bethlehem, and Allentown all represent significant patient populations with high average order values and strong repeat purchase rates. Suburban patients often have fewer dispensary options, which means a well-run loyalty program can lock in customer lifetime value that urban locations struggle to match.
When recreational passes, many new licenses will target urban centers first. Suburban dispensaries that have already built strong loyalty programs will be insulated from that first wave of competition. Rural operators in central and northern Pennsylvania have even more runway but should still be building their databases now. The patients you capture in a low-competition environment are the easiest to retain when competition arrives.
Portfolio observation: A dispensary group operating in both Philadelphia and Pittsburgh found that their Pittsburgh locations had 22% higher repeat purchase rates but 35% lower average order values compared to Philadelphia. The takeaway is not that one market is better. It is that each requires a different retention strategy calibrated to local purchasing behavior. Check our 2026 email benchmarks report for more on regional performance differences.
Frequently Asked Questions
These are the questions we hear most from Pennsylvania dispensary operators preparing for the recreational transition.
When will Pennsylvania legalize recreational cannabis?
HB 1200, the primary adult-use legalization bill, has been introduced with growing bipartisan support and is advancing through committee. Governor Shapiro has publicly signaled support for adult-use legalization on multiple occasions, framing it as both a revenue opportunity and a social equity priority. While no bill has a guaranteed timeline, most industry analysts and lobbyists in Harrisburg expect meaningful legislative progress within the next 12 to 18 months. The operators who treat this as inevitable and begin preparing now will have a significant structural advantage over those who wait for a signature before they act.
How should PA medical dispensaries prepare for recreational sales?
Start with your customer database. Integrate your POS with a cannabis-specific CRM like Alpine IQ, Dutchie, or Springbig. Enroll every patient in email and SMS programs with proper TCPA-compliant opt-in. Launch a loyalty program that rewards repeat visits and increases switching costs. Build compliant marketing templates that can be adapted when rec rules are finalized. Train your budtenders on consistent messaging. The goal is to convert every medical patient into a retained customer before the recreational flood of new competitors and new consumers arrives. Every week you wait is a week of patient data and loyalty equity you are not building.
What marketing is allowed for Pennsylvania medical cannabis?
Pennsylvania DOH rules prohibit therapeutic claims beyond the list of approved qualifying conditions. All advertising must include your dispensary permit number and can only be placed in media where at least 70% of the audience is reasonably expected to be 18 or older. Patient privacy under HIPAA must be maintained in all communications, and any email platform you use must have a Business Associate Agreement in place. Social media content cannot make health claims or target minors. When recreational arrives, additional restrictions around outdoor advertising, proximity to schools, and youth-appeal content will likely be added, similar to the frameworks in New Jersey and Illinois.
How do PA dispensaries compete with New Jersey's recreational market?
The most effective defense against patient leakage to New Jersey is a strong retention program. Patients who are enrolled in a loyalty program, who receive personalized communications based on their purchase history, and who have a genuine relationship with their dispensary are far less likely to make the drive to NJ for a recreational purchase. Pre-order and express pickup capabilities reduce the convenience gap. The dispensaries losing the most patients to NJ are consistently the ones with no loyalty program, no personalized marketing, and no systematic approach to customer communication. Build retention infrastructure and the border problem shrinks considerably.